Week 9 Pharmacokinetics: IV Infusion Kinetics

Lecture Notes

1 Overview

This lecture covers intravenous (IV) infusion pharmacokinetics, with a focus on the conceptual and mathematical framework governing drug input during constant-rate infusions, the relationship between infusion kinetics and multiple-dose pharmacokinetics, and the attainment of steady state.


2 1. Introduction to IV Infusion

IV infusion is a route of administration in which drug is delivered into the body at a constant rate over a defined period of time. Understanding infusion kinetics provides the conceptual foundation for understanding multiple-dose pharmacokinetics.

2.1 1.1 Dosing Rate: A Unifying Concept

When a drug is administered at any route of administration with a defined frequency, the dose per unit time can be expressed as a dosing rate. For example, 100 mg administered orally every 24 hours corresponds to a dosing rate of:

\[\text{Dosing Rate} = \frac{100 \text{ mg}}{24 \text{ h}}\]

This concept applies regardless of route — oral, IV bolus, subcutaneous, intramuscular, or infusion.

2.2 1.2 Infusion Rate and Duration

For an IV infusion, the two most clinically important input parameters are:

  • Infusion rate — the speed at which the drug is administered (e.g., mg/min or mL/min)
  • Infusion duration — the total time over which drug is delivered

Example: Suppose the goal is to deliver a 100 mg dose from an IV bag. The bag has a volume of 100 mL at a concentration of 5 mg/mL, giving a total drug content of 500 mg. Since only 100 mg is needed, only 20 mL of the bag needs to be infused. If the infusion pump is set to 1 mL/min, the infusion duration is 20 minutes.

The clinician may choose any combination of rate and duration that delivers the required dose. This decision is influenced by clinical, pharmacological, and operational factors.


3 2. Steady State and the Concept of Rate Balance

3.1 2.1 What is Steady State?

Steady state is the condition at which the rate of drug input into the body equals the rate of drug elimination from the body:

\[\text{Rate of Input} = \text{Rate of Elimination}\]

At steady state, the net change in drug amount (or concentration) in the body is zero. This is analogous to a tank with a constant inflow and outflow of water reaching a stable level.

3.2 2.2 Time to Steady State and Half-Life

The time required to reach steady state is governed by the elimination half-life of the drug, regardless of the route of administration. It takes approximately four to five half-lives to reach approximately 97–99% of steady state.

Half-Life Number Fraction Remaining
1 50%
2 25%
3 12.5%
4 6.25%
5 ~3%

This principle applies universally — for oral multiple-dose regimens, IV infusions, and any other route.

3.3 2.3 What Determines the Dosing Rate?

To achieve a target exposure at steady state, the dosing rate is determined by two quantities:

  1. Clearance (CL) — the fundamental pharmacokinetic parameter governing drug elimination
  2. Target steady-state concentration (C_ss) — the desired plasma concentration at steady state

At steady state:

\[\text{Rate of Input} = \text{Rate of Elimination} = CL \times C_{ss}\]

Therefore:

\[K_0 = CL \times C_{ss}\]

where \(K_0\) is the infusion rate (zero-order input rate). If clearance is known and a target \(C_{ss}\) is defined, the required infusion rate can be calculated directly.

3.4 2.4 Steady-State Concentration as an Exposure Metric

A common clinical practice is to measure the trough concentration (\(C_{trough}\), also denoted \(C_{min}\)) at steady state — the concentration just before the next dose. This is favored primarily for logistical reasons: patients return to the clinic for the next dose, making it operationally straightforward to collect a pre-dose sample. Depending on the drug and the pharmacodynamic relationship, the relevant exposure metric at steady state may be \(C_{max}\), \(C_{trough}\), or area under the curve (AUC). The selection is drug- and disease-specific.


4 3. Zero-Order Input and First-Order Elimination

4.1 3.1 Nature of Infusion Input

In oral dosing, drug absorption from the gastrointestinal tract is a first-order process — the rate of absorption depends on the amount of drug remaining at the absorption site (depot):

\[\frac{dA_{depot}}{dt} = -k_a \cdot A_{depot}\]

In an IV infusion, drug is delivered directly into the systemic circulation at a preset, constant rate that is independent of the amount of drug remaining in the IV bag. This is a zero-order input:

\[\frac{dA}{dt}\bigg|_{\text{in}} = K_0\]

4.2 3.2 Differential Equation for IV Infusion

The rate of change of the amount of drug in the body during a constant-rate IV infusion is:

\[\frac{dA}{dt} = K_0 - k_{el} \cdot A\]

where: - \(K_0\) = zero-order infusion rate (e.g., mg/h) - \(k_{el}\) = first-order elimination rate constant (h⁻¹) - \(A\) = amount of drug in the body at time \(t\)

At steady state, \(\frac{dA}{dt} = 0\), which gives:

\[K_0 = k_{el} \cdot A_{ss} = k_{el} \cdot V \cdot C_{ss} = CL \cdot C_{ss}\]


5 4. Short Infusions vs. Long Infusions

5.1 4.1 Short Infusions

A short infusion is one where the drug is administered over a brief period and stopped before reaching steady state. After the infusion ends, the plasma concentration follows a simple exponential decline — identical to the post-dose decline observed with IV bolus administration:

\[C(t) = C_0 \cdot e^{-k_{el} \cdot t}\]

where \(C_0\) is the concentration at the end of the infusion (equivalent to \(C_{max}\) for a short infusion).

Short infusions behave pharmacokinetically like any other single-dose route of administration once the input has stopped. Multiple short infusions given at defined intervals are analogous to multiple-dose oral regimens, approaching steady state over four to five half-lives.

5.2 4.2 Long Infusions

A long infusion is one that is continued until steady state is achieved. During the infusion, plasma concentration rises exponentially toward \(C_{ss}\):

\[C(t) = \frac{K_0}{CL} \cdot \left(1 - e^{-k_{el} \cdot t}\right) = C_{ss} \cdot \left(1 - e^{-k_{el} \cdot t}\right)\]

This equation describes a mirror image of the post-infusion exponential decline. The approach to steady state is mono-exponential for a one-compartment model.

Once the infusion is stopped (at time \(T_{end}\)), the concentration declines as:

\[C(t) = C_{ss} \cdot e^{-k_{el} \cdot (t - T_{end})}\]

5.3 4.3 General Concentration Equations During and After Infusion

Phase Equation
During infusion \(C(t) = C_{ss} \cdot \left(1 - e^{-k_{el} \cdot t}\right)\)
At steady state (during continued infusion) \(C = C_{ss}\)
After infusion stops \(C(t) = C_{ss} \cdot e^{-k_{el} \cdot (t - T_{end})}\)

6 5. Measuring Concentrations During Infusion

From a strictly mathematical standpoint, if the following are known:

  • The infusion rate (\(K_0\))
  • The drug clearance (\(CL\)) and volume of distribution (\(V\))
  • The target steady-state concentration (\(C_{ss}\))

Then plasma concentrations at any time point during the infusion can be predicted without measurement, using:

\[C(t) = C_{ss} \cdot \left(1 - e^{-k_{el} \cdot t}\right)\]

Accordingly, if a truly constant-rate infusion is being administered and the pharmacokinetic parameters are already characterized, collecting samples during the infusion adds limited additional information. The post-infusion concentration–time data alone are sufficient to estimate the relevant parameters.


7 6. Loading Doses Combined with Maintenance Infusions

7.1 6.1 Rationale

The time required to reach steady state via a constant-rate infusion alone is four to five half-lives. For drugs with long half-lives, this delay may be clinically unacceptable. A loading dose (IV bolus) administered simultaneously at the start of the infusion allows the plasma concentration to reach \(C_{ss}\) immediately.

7.2 6.2 Combined Equation

When an IV bolus (loading dose) and a constant-rate infusion are given simultaneously, the total plasma concentration is the sum of contributions from each:

\[C(t) = \underbrace{C_{ss} \cdot \left(1 - e^{-k_{el} \cdot t}\right)}_{\text{infusion}} + \underbrace{C_0 \cdot e^{-k_{el} \cdot t}}_{\text{bolus}}\]

where \(C_0 = \frac{\text{Loading Dose}}{V}\).

7.3 6.3 Optimal Loading Dose

If the loading dose is chosen such that \(C_0 = C_{ss}\), the two exponential terms cancel:

\[C(t) = C_{ss} \cdot \left(1 - e^{-k_{el} \cdot t}\right) + C_{ss} \cdot e^{-k_{el} \cdot t} = C_{ss}\]

The plasma concentration is constant at \(C_{ss}\) from time zero onward — there is no transient approach phase. The required loading dose is therefore:

\[\text{Loading Dose} = C_{ss} \cdot V\]

7.4 6.4 Effect of Suboptimal Loading Dose

If \(C_0 \neq C_{ss}\), the concentration–time profile will show an initial transient that either rises toward \(C_{ss}\) (if \(C_0 < C_{ss}\)) or falls toward \(C_{ss}\) (if \(C_0 > C_{ss}\)) before converging to the steady-state plateau. The infusion component continues to drive the system toward \(C_{ss}\) in either case; the loading dose only alters how quickly the apparent steady state is reached from the combined-dose perspective.


8 7. Summary of Key Concepts

  1. Zero-order input, first-order elimination characterizes IV infusion pharmacokinetics.
  2. Steady state is achieved when the rate of infusion equals the rate of elimination: \(K_0 = CL \cdot C_{ss}\).
  3. Time to steady state depends on the elimination half-life and is independent of the infusion rate; it takes approximately four to five half-lives.
  4. Short infusions behave like IV bolus doses after the infusion ends; multiple short infusions accumulate to steady state similarly to multiple oral doses.
  5. Long infusions produce an exponential approach to \(C_{ss}\), described by \(C(t) = C_{ss}(1 - e^{-k_{el} t})\).
  6. Concentration during infusion can be predicted mathematically if \(CL\), \(V\), and \(K_0\) are known; sampling during the infusion may not always add analytical value.
  7. Loading doses can be combined with maintenance infusions to achieve \(C_{ss}\) immediately; the optimal loading dose is \(C_{ss} \cdot V\).
  8. All infusion concepts reduce to the same mathematical framework as IV bolus kinetics — the post-infusion decline is \(e^{-k_{el} t}\), and the approach to maximum is \(1 - e^{-k_{el} t}\), its mirror image.